ONCOLOGY

Pathologic Fractures

Jul 21, 2016 by in ONCOLOGY Comments Off on Pathologic Fractures

Pathologic Fractures Timothy A. Damron A pathologic fracture is defined as one occurring in abnormal bone. The abnormality in the bone may be due to metabolic diseases (such as osteoporosis,…

read more

Malignant Bone Lesions

Jul 21, 2016 by in ONCOLOGY Comments Off on Malignant Bone Lesions

Malignant Bone Lesions Francis R. Patterson Timothy A. Damron Carol D. Morris Malignancies involving bone include metastatic disease, myeloma, lymphoma, and bone sarcoma. Treatment options include surgery, radiotherapy, and chemotherapy….

read more

Soft Tissue Tumors

Jul 21, 2016 by in ONCOLOGY Comments Off on Soft Tissue Tumors

Soft Tissue Tumors John Heiner Jeremy White The treatment of soft tissue tumors is dictated strictly by the diagnosis. Based on the pathology of the tumor, appropriate treatment can involve…

read more

Benign Tumors of Bone

Jul 21, 2016 by in ONCOLOGY Comments Off on Benign Tumors of Bone

Benign Tumors of Bone Cynthia M. Kelly Musculoskeletal tumors are, in general, uncommon problems, and malignant tumors of bone are considered rare. Comparatively speaking, benign tumors of bone are more…

read more

Surgical Margins

Jul 21, 2016 by in ONCOLOGY Comments Off on Surgical Margins

Surgical Margins Robert Quinn Appropriate surgical planning for the treatment of musculoskeletal tumors requires proper histologic diagnosis and staging. The type of surgical margin most appropriate for a given tumor…

read more

Biopsy of Musculoskeletal Tumors

Jul 21, 2016 by in ONCOLOGY Comments Off on Biopsy of Musculoskeletal Tumors

Biopsy of Musculoskeletal Tumors Edward A. Athanasian Biopsy of musculoskeletal bone and soft tissue tumors may appear to be a deceptively easy technical surgical procedure. Patients may also perceive biopsy…

read more

Evaluation of Soft Tissue Tumors

Jul 21, 2016 by in ONCOLOGY Comments Off on Evaluation of Soft Tissue Tumors

Evaluation of Soft Tissue Tumors Carol D. Morris Soft tissue tumors are heterogeneous in their behavior and management. The vast majority of soft tissue tumors are benign, with benign tumors…

read more

Evaluation of Bone Tumors

Jul 21, 2016 by in ONCOLOGY Comments Off on Evaluation of Bone Tumors

Evaluation of Bone Tumors Timothy A. Damron Bone lesions can be difficult to identify specifically, and arriving at a specific diagnosis can elude even the most experienced orthopaedic oncologist. However,…

read more

Unit III. Combination Chemotherapy Regimens

Jul 20, 2016 by in ONCOLOGY Comments Off on Unit III. Combination Chemotherapy Regimens

Unit III. Combination Chemotherapy Regimens The use of combination chemotherapy is well established. Combining agents have allowed the clinician to achieve maximum cell kill while trying to minimize toxicity to…

read more

♦Vinorelbine

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Vinorelbine

♦Vinorelbine (vin-oh-rel-been’) Navelbine Pregnancy Category D Mechanism of Action An antimitotic agent that inhibits microtubule formation by interfering with nucleic acid synthesis. Indications Non-small cell lung cancer, breast cancer, ovarian…

read more
Get Clinical Tree app for offline access